
Publication
Houston, we have insurance!
For decades, space activity has captured our collective imagination but the reality of space commercialisation has shunned the spotlight.
Australie | Publication | juin 2023
Canberra’s winter presents a delightful combination of frosty mornings below freezing and glorious, sun-filled days. Having now hit our shortest (and coldest) day of the year and with the countdown to spring on, grab that cosy blanket (or puffer jacket) and mosey through our winter publication of the Commonwealth Quarterly.
We are excited to offer a variety of articles this edition:
If you have any questions on any of our articles please do not hesitate to reach out.
Keep warm and stay safe!
Holly McAdam
Partner and Head of Office
Canberra
Ella Fisher
Paralegal and Editor of the CQ
Canberra
Publication
For decades, space activity has captured our collective imagination but the reality of space commercialisation has shunned the spotlight.
Publication
Since the commencement of the Offshore Electricity Infrastructure Act 2021 (Cth) (‘OEI Act’) in June 2022, there has been a flurry of activity in the domestic offshore wind space.
Publication
While Australians are a famously relaxed bunch, governments are typically held to a higher standard - especially when it comes to decisions around expenditure.
Publication
The Federal Court of Appeal (FCA) in Canada v Vefghi Holding Corp recently released a highly anticipated decision regarding the timing for determining when two corporations interposed by a trust, hereinafter referred to as the Paying Corporation and the Corporate Beneficiary, must be “connected” for purposes of applying Part IV tax.
Publication
Le Programme des marchandises contrôlées (PMC) est le programme national de sécurité industrielle du Canada qui réglemente l’examen, la possession et le transfert des marchandises contrôlées.
Publication
Santé Canada a proposé un changement important à la réglementation des médicaments biosimilaires qui pourrait accélérer les litiges liés aux brevets visant des médicaments biologiques au Canada.
Abonnez-vous et restez à l’affût des nouvelles juridiques, informations et événements les plus récents...
© Norton Rose Fulbright LLP 2025